| Literature DB >> 33546294 |
Jing Zhang1, Yaling Tan1, Guorong Li1, Lexian Chen1, Minyi Nie1, Zhaohua Wang2, Hong Ji1.
Abstract
Coumarins possesses immeasurable antitumor potential with minimum side effects depending on the substitutions on the basic nucleus, which exhibits great prospects for antitumor drug development. In an attempt to develop novel antitumor candidates, a series of coumarin sulfonamides and amides derivatives were designed and synthetized. The majority of these derivatives showed good cytotoxic activity against MDA-MB-231 and KB cell lines, among which compound 9c was the most potent against MDA-MB-231 cells, with IC50 value of 9.33 μM, comparable to 5-fluorouracil. Further investigation revealed that compound 9c had versatile properties against tumors, including inhibition of cell migration and invasion as well as inducing apoptosis. Reactive oxygen species (ROS) assay and western blotting analysis suggested that compound 9c promoted cancer cell apoptosis by increasing ROS levels and upregulating the expression of caspase-3 in MDA-MB-231 cells. These results indicated that compound 9c could be promising lead compound for further antitumor drug research.Entities:
Keywords: MDA-MB-231; antitumor; coumarin amides; coumarin sulfonamides
Mesh:
Substances:
Year: 2021 PMID: 33546294 PMCID: PMC7913302 DOI: 10.3390/molecules26040786
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411